From Medscape Rheumatology

Coverage from the

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2025 Annual Meeting and Trainee Symposium

July 10 - 12, 2025; Bogotá, Colombia

July 10 - 12, 2025Bogotá, Colombia

Conference News

GRAPPA 2025 Ultrasound-Based Diagnosis of Early PsA Remains Elusive
Medscape Medical News, August 12, 2025
GRAPPA 2025 Support Needed for Psoriasis Patients’ Poor-Quality Sleep
Medscape Medical News, August 11, 2025
GRAPPA 2025 Body Composition, Not Just BMI, Matters in Psoriatic Disease
Medscape Medical News, August 1, 2025
GRAPPA 2025 Study Pinpoints Candidiasis Risk With Dual IL-17A/F Blockade
Medscape Medical News, July 28, 2025

GRAPPA 2025 Secukinumab in Early PsA Starts Fast vs Standard of Care
Medscape Medical News, July 28, 2025
GRAPPA 2025 Role of GLP-1 Drugs in Psoriasis and PsA Is Debated
Medscape Medical News, July 22, 2025
GRAPPA 2025 New Definitions Refine Difficult-to-Treat PsA
Medscape Medical News, July 18, 2025
GRAPPA 2025 Exercise Affects PsA Risk in Patients With Psoriasis
Medscape Medical News, July 15, 2025

Medscape Rheumatology©

Popular News From GRAPPA 2024

MSK Symptoms, Psoriasis: Dermatologists or Rheumatologists? A dermatologist argues for a role to prevent psoriatic arthritis, but rheumatologist favors experience in diagnosis.
Medscape Medical News, Jul 19, 2024
MHC-1-Opathies Linked to Ancient Retrovirus Infections Psoriasis is one of several autoimmune diseases linked to variations in MHC-1 that may have protected our ancestors from retroviruses.
Medscape Medical News, Jul 25, 2024

Previous Coverage

Related Resources